National Neuroscience Institute

Running trials

• Recruiting

  A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

  NCT07091630· Phase 3· argenx· Source

• Recruiting

  A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  NCT06920004· Phase 3· argenx· Source

• Recruiting

  A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

  NCT07033494· Phase 2· Merck Sharp & Dohme LLC· Source

• Recruiting

  Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature

  NCT06894225· Phase 2· National Neuroscience Institute· Source

• Active, not recruiting

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

  NCT05580562· Phase 3· Jazz Pharmaceuticals· Source

• Recruiting

  RESTORES Trial: RESToration Of Rehabilitative Function With Epidural Spinal Stimulation

  NCT05644171· National Neuroscience Institute· Source

• Active, not recruiting

  Tocotrienols in Parkinson's Disease (PD)

  NCT04491383· Phase 2· National Neuroscience Institute· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• CIDP (chronic inflammatory demyelinating polyneuropathy)2 recruiting
• Alzheimer disease1 recruiting
• Childhood cancers1 recruiting
• Glioblastoma1 recruiting
• Spinal cord injury1 recruiting

Conditions

Diseases this institution publishes on or runs trials for.

• Parkinson disease64 works · 1 trial
• Essential tremor5 works · 0 trials